-
581
Relationship between Tai Chi and clinical outcomes in elderly patients with COVID-19: a protocol for systematic review and dose–response meta-analysis
Published 2022-12-01“…The results will be disseminated through peer-reviewed publications.PROSPERO registration number CRD42022327694.…”
Get full text
Article -
582
-
583
-
584
Systematic Review with Network Meta-Analysis: Comparative Efficacy and Safety of Combination Therapy with Angiotensin II Receptor Blockers and Amlodipine in Asian Hypertensive Pati...
Published 2019-01-01“…The analysis included 1198 Asian HTN patients from seven studies involving six ARB-AML CTs: azilsartan (AZL), candesartan (CAN), fimasartan (FIM), losartan (LOS), olmesartan (OLM), and telmisartan (TEL). …”
Get full text
Article -
585
Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights
Published 2025-02-01“…A phase III clinical trial is ongoing in China (NCT05868707).Conclusions OH2 oncolytic virotherapy exhibited a favorable safety profile without dose-limiting toxicities (DLTs) and demonstrated durable antitumor efficacy in patients with melanoma, especially in those who had progressed on anti-PD-1 treatment.Trial registration number ClinicalTrials.gov identifier NCT04386967.…”
Get full text
Article -
586
-
587
-
588
-
589
-
590
-
591
-
592
-
593
-
594
Characteristics of CTEV Patients at Orthopedic and Traumatology Outpatient Clinic in Datu Beru General Hospital Takengon Central Aceh Period August 2018-July 2022
Published 2022-10-01“…Conclusion: Males 15 cases (53.6%) and females 13 cases (46.4%). The age of patient's brought by parents was mostly1-6 months, with as many as 12 cases (42.9%). …”
Get full text
Article -
595
-
596
-
597
-
598
-
599
-
600
Efficacy and Safety of Dapagliflozin versus Liraglutide in Patients with Overweight or Obesity and Type 2 Diabetes Mellitus: A Randomised Controlled Clinical Trial in Tianjin, Chin...
Published 2022-01-01“…After COVID-19 outbreak, the number of patients taking sleep-promoting drugs increased from 4.9% to 9.4% (p=0.029). …”
Get full text
Article